Mitotic rate as an important prognostic factor in cutaneous malignant melanoma

Clin Transl Oncol. 2019 Oct;21(10):1348-1356. doi: 10.1007/s12094-019-02064-4. Epub 2019 Feb 19.

Abstract

Background: Recently, the quantification of mitoses in cutaneous melanoma has been discharged from the main prognostic variables of the TNM classification.

Objective: To investigate the prognostic value of the presence of mitoses in primary cutaneous melanoma and to establish the number of mitoses per mm2 that may have prognostic significance.

Methods: A retrospective observational study was performed on 141 patients treated for cutaneous melanoma, who were assessed by the same pathologist, and who had a minimum follow-up of 2 years. Clinical, epidemiological, histopathological and follow-up variables were gathered and compared with the number of mitoses to distinguish the significance of differences by means of univariate, multivariate, and survival analyses.

Results: The cut-off level related to a better sensitivity and specificity was 1.50 mitoses per mm2. The presence of two or more mitoses/mm2 showed a better relationship with prognostic variables and both the overall and disease-free survival than the presence of 1 or more mitoses/mm2. This happens especially in melanomas thicker than 0.8 mm and it could affect the staging in cases with Breslow between 1 and 2 mm.

Conclusions: A mitotic rate of two or more mitoses per mm2 in cutaneous melanoma should be considered as a more accurate prognostic factor than one or more mitoses per mm2, particularly in tumors equal or greater than 0.8 mm in thickness.

Keywords: Cut-off; Cutaneous melanoma; Mitosis; Prognostic.

Publication types

  • Observational Study

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Aged, 80 and over
  • Analysis of Variance
  • Child
  • Disease-Free Survival
  • Female
  • Humans
  • Male
  • Melanoma / mortality*
  • Melanoma / pathology*
  • Melanoma, Cutaneous Malignant
  • Middle Aged
  • Mitotic Index*
  • Neoplasm Staging / standards
  • Prognosis
  • ROC Curve
  • Reference Values
  • Retrospective Studies
  • Sensitivity and Specificity
  • Sentinel Lymph Node Biopsy
  • Skin Neoplasms / mortality*
  • Skin Neoplasms / pathology*
  • Survival Analysis
  • Young Adult

Grants and funding